Chenshi Lin
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 10%
Papers in
-
- Pulmonary Hypertension Research and Treatments 2
- Co-authors
- Wei He (6 shared papers)Chao Teng (5 shared papers)Min Qiu (1 shared paper)Xiaotong Li (1 shared paper)Makhloufi Zoulikha (1 shared paper)Qingqing Xiao (1 shared paper)Marwa A. Sallam (1 shared paper)Qiaobing Xu (1 shared paper)
- Journals
- Acta Pharmaceutica Sinica B (2 papers)Medicine (1 paper)Carbohydrate Polymers (1 paper)Burns & Trauma (1 paper)Advanced Drug Delivery Reviews (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Chenshi Lin
16 papers receiving 621 citations
Chenshi Lin's Hit Papers
Peers
Comparison fields: 5 of 87
- Biomaterials 241
- Pharmaceutical Science 33
- Biomedical Engineering 211
- Molecular Biology 224
- Cancer Research 42
Countries citing papers authored by Chenshi Lin
This map shows the geographic impact of Chenshi Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenshi Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenshi Lin more than expected).
Fields of papers citing papers by Chenshi Lin
This network shows the impact of papers produced by Chenshi Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenshi Lin. The network helps show where Chenshi Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Chenshi Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 209 | |
| 2 | The effects of protein corona on in vivo fate of nanocarriers Hit paper breakdown → | 2022 | 184 |
| 3 | 2023 | 59 | |
| 4 | 2020 | 47 | |
| 5 | 2021 | 39 | |
| 6 | 2022 | 26 | |
| 7 | 2019 | 21 | |
| 8 | 2021 | 18 | |
| 9 | 2023 | 8 | |
| 10 | 2025 | 4 | |
| 11 | 2022 | 3 | |
| 12 | 2022 | 2 | |
| 13 | 2025 | 1 | |
| 14 | 2026 | 1 | |
| 15 | 2023 | 1 | |
| 16 | 2014 | 1 | |
| 17 | 2026 | 0 | |
| 18 | 2025 | 0 | |
| 19 | 2022 | 0 | |
| 20 | 2025 | 0 |
About Chenshi Lin
Chenshi Lin is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Biomaterials, Endocrinology, Diabetes and Metabolism and Surgery, having authored 21 papers that have together received 624 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (4 papers), Diabetes Treatment and Management (2 papers), Pulmonary Hypertension Research and Treatments (2 papers), MicroRNA in disease regulation (2 papers), Nanoplatforms for cancer theranostics (2 papers), Case Reports on Hematomas (1 paper), Polymer Surface Interaction Studies (1 paper) and Hormonal and reproductive studies (1 paper). The work is most often cited by research in Biomaterials (241 citations), Pharmaceutical Science (33 citations), Biomedical Engineering (211 citations), Molecular Biology (224 citations) and Cancer Research (42 citations). Chenshi Lin has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Wei He, Chao Teng, Min Qiu, Xiaotong Li, Makhloufi Zoulikha, Qingqing Xiao, Marwa A. Sallam, Qiaobing Xu, Lei Yang and Chao Qin. Their work appears in journals such as Acta Pharmaceutica Sinica B, Medicine, Carbohydrate Polymers, Burns & Trauma and Advanced Drug Delivery Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.